A detailed history of Ropes Wealth Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 2,068 shares of BIIB stock, worth $359,397. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,068
Previous 2,088 0.96%
Holding current value
$359,397
Previous $594,000 10.61%
% of portfolio
0.1%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$253.3 - $285.89 $5,066 - $5,717
-20 Reduced 0.96%
2,068 $531,000
Q2 2023

Aug 07, 2023

SELL
$275.25 - $318.06 $37,158 - $42,938
-135 Reduced 6.07%
2,088 $594,000
Q1 2023

May 08, 2023

BUY
$256.56 - $292.34 $4,361 - $4,969
17 Added 0.77%
2,223 $618,000
Q4 2022

Feb 06, 2023

BUY
$252.44 - $306.72 $757 - $920
3 Added 0.14%
2,206 $610,000
Q3 2022

Nov 01, 2022

SELL
$194.69 - $268.46 $15,185 - $20,939
-78 Reduced 3.42%
2,203 $588,000
Q2 2022

Aug 10, 2022

SELL
$187.54 - $223.02 $108,585 - $129,128
-579 Reduced 20.24%
2,281 $465,000
Q1 2022

May 04, 2022

SELL
$193.77 - $244.14 $7,363 - $9,277
-38 Reduced 1.31%
2,860 $602,000
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $3,806 - $4,892
-17 Reduced 0.58%
2,898 $695,000
Q3 2021

Nov 05, 2021

BUY
$282.99 - $369.05 $4,244 - $5,535
15 Added 0.52%
2,915 $825,000
Q2 2021

Aug 04, 2021

SELL
$259.0 - $414.71 $343,434 - $549,905
-1,326 Reduced 31.38%
2,900 $1 Million
Q1 2021

May 12, 2021

BUY
$242.95 - $284.63 $72,885 - $85,389
300 Added 7.64%
4,226 $1.18 Million
Q3 2020

Oct 16, 2020

SELL
$264.77 - $305.71 $2,118 - $2,445
-8 Reduced 0.2%
3,926 $1.11 Million
Q2 2020

Jul 20, 2020

BUY
$258.66 - $342.55 $2,069 - $2,740
8 Added 0.2%
3,934 $1.05 Million
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $1.1 Million - $1.29 Million
3,926
3,926 $1.23 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.